Intellia’s in vivo gene therapy victorious in Phase III HAE trial

Clinical Trials Arena·Apr 27

This story is reported by Clinical Trials Arena. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

Intellia says CRISPR-based treatment for rare disease reduced swelling attacks in pivotal trial

STAT·Apr 27

2

Intellia Therapeutics: Why The Clinical Hold Lift Isn't A Total Victory

Seeking Alpha·Mar 9

3

NTLA Stock Surges 35% Overnight: Retail Mood Peaks Ahead Of First-Ever Phase 3 Readout For Gene-Editing Therapy

Stocktwits·1h ago